⌘K

Home/Filings/4/0001214659-19-005092

4//SEC Filing

Brister Mark 4

Accession 0001214659-19-005092

CIK 0001427570other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 2:28 PM ET

Size

7.0 KB

Accession

0001214659-19-005092

Insider Transaction Report

Form 4

Period: 2019-08-06

OBALON THERAPEUTICS INCOBLN

VP of Research and Development

Transactions

Purchase
Warrants (Right to Buy)
2019-08-06+3,750→ 3,750 total
Exercise: $4.40From: 2019-08-06Exp: 2024-08-06→ Common Stock (3,750 underlying)
Purchase
Common Stock
2019-08-06$4.00/sh+5,000$20,000→ 38,865 total

Footnotes (2)

[F1]Reflects price paid to underwriters in Issuer's registered offering.
[F2]Includes Restricted Shares that are subject to vesting.

Documents

1 file

4
marketforms-45427.xmlPrimary
PRIMARY DOCUMENT

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001323223

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 2:28 PM ET
Size: 7.0 KB

View on SEC.gov